Pluristem (Israel) Signs MOU for Collaboration with Fukushima Medical University to Study PLX-R18 in Acute Radiation Syndrome

Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products, has signed a Memorandum of Understanding (MOU) for a collaboration withFukushima Medical University, Fukushima Global Medical Science Center. The purpose of the collaboration is to develop Pluristem’s PLX-R18 cells…